Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|December 22, 2010
A novel epigenetic phenotype associated with the most aggressive pathway of bladder tumor progressionCéline Vallot, Nicolas Stransky, Isabelle Bernard-Pierrot, et al.
Carcinogenesis|December 13, 2005
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3bIsabelle Bernard-Pierrot, Aude Brams, Claire Dunois-Lardé, et al.
International Journal of Biological Sciences|January 3, 2023
Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transitionSara Monteiro-Reis, Vera Miranda-Gonçalves, Catarina Guimarães-Teixeira, et al.
European Urology|April 13, 2019
APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder CancerMing-Jun Shi, Xiang-Yu Meng, Philippe Lamy, et al.
Immunity|October 16, 2016
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of EomesCaroline Stienne, Michaël F Michieletto, Mehdi Benamar, et al.
Bioorganic & Medicinal Chemistry|October 13, 2018
Design, synthesis, biological evaluation and cellular imaging of imidazo[4,5-b]pyridine derivatives as potent and selective TAM inhibitorsTom Baladi, Jessy Aziz, Florent Dufour, et al.
The Journal of Pathology|January 25, 2023
Progression-associated molecular changes in basal/squamous and sarcomatoid bladder carcinogenesisJacqueline Fontugne, Jennifer Wong, Luc Cabel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the ratEmmanuel Xystrakis, Pierre Cavailles, Anne S Dejean, et al.
The Journal of Experimental Medicine|September 28, 2011
The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell developmentCéline Colacios, Audrey Casemayou, Anne S Dejean, et al.
Pageof 9